These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16600250)

  • 1. Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI.
    Corti R; Osende J; Hutter R; Viles-Gonzalez JF; Zafar U; Valdivieso C; Mizsei G; Fallon JT; Fuster V; Badimon JJ
    Atherosclerosis; 2007 Jan; 190(1):106-13. PubMed ID: 16600250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging.
    Corti R; Osende JI; Fallon JT; Fuster V; Mizsei G; Jneid H; Wright SD; Chaplin WF; Badimon JJ
    J Am Coll Cardiol; 2004 Feb; 43(3):464-73. PubMed ID: 15013132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin and fenofibrate combination induces the predominance of the large HDL subclasses and increased apo AI fractional catabolic rates in New Zealand white rabbits with exogenous hypercholesterolemia.
    Flores-Castillo C; Zamora-Pérez JÁ; Carreón-Torres E; Arzola-Paniagua A; Aguilar-Salinas C; López-Olmos V; Fragoso JM; Luna-Luna M; Rodríguez-Pérez JM; Franco M; Vargas-Alarcón G; Pérez-Méndez Ó
    Fundam Clin Pharmacol; 2015 Aug; 29(4):362-70. PubMed ID: 25982284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of peroxisome proliferator-activated receptor α in atherosclerosis.
    Cao H; Wen G; Li H
    Mol Med Rep; 2014 May; 9(5):1755-60. PubMed ID: 24604149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of fenofibrate on plaque thrombogenicity and plaque stability in atherosclerotic rabbits.
    Jeanpierre E; Le Tourneau T; Zawadzki C; Van Belle E; Mouquet F; Susen S; Ezekowitz MD; Staels B; Jude B; Corseaux D
    Cardiovasc Pathol; 2009; 18(3):140-7. PubMed ID: 18436454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrate treatment induced quantitative and qualitative HDL changes associated with an increase of SR-BI cholesterol efflux capacities in rabbits.
    Fournier N; Tuloup-Minguez V; Pourci ML; Thérond P; Jullian JC; Wien F; Leroy M; Dallongeville J; Paul JL; Leroy A
    Biochimie; 2013 Jun; 95(6):1278-87. PubMed ID: 23410672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed.
    Prasad K
    Atherosclerosis; 2008 Mar; 197(1):34-42. PubMed ID: 17904562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.
    Hirano T; Yamashita S; Takahashi M; Hashimoto H; Mori Y; Goto M
    Metabolism; 2016 Jun; 65(6):893-903. PubMed ID: 27173468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanolic extract of Artemisia aucheri induces regression of aorta wall fatty streaks in hypercholesterolemic rabbits.
    Asgary S; Dinani NJ; Madani H; Mahzouni P
    Pharmazie; 2008 May; 63(5):394-7. PubMed ID: 18557427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL (High-Density Lipoprotein) Remodeling and Magnetic Resonance Imaging-Assessed Atherosclerotic Plaque Burden: Study in a Preclinical Experimental Model.
    Ben-Aicha S; Casaní L; Muñoz-García N; Joan-Babot O; Peña E; Aržanauskaitė M; Gutierrez M; Mendieta G; Padró T; Badimon L; Vilahur G
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2481-2493. PubMed ID: 32847390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits.
    Spartalis M; Siasos G; Mastrogeorgiou M; Spartalis E; Kaminiotis VV; Mylonas KS; Kapelouzou A; Kontogiannis C; Doulamis IP; Toutouzas K; Nikiteas N; Iliopoulos DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7765-7776. PubMed ID: 34982438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCM-198 attenuates early atherosclerotic lesions in hypercholesterolemic rabbits via modulation of the inflammatory and oxidative stress pathways.
    Zhang Y; Guo W; Wen Y; Xiong Q; Liu H; Wu J; Zou Y; Zhu Y
    Atherosclerosis; 2012 Sep; 224(1):43-50. PubMed ID: 22840690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-hyperlipidemic and anti-atherosclerotic effects of Pinus eldarica Medw. nut in hypercholesterolemic rabbits.
    Huseini HF; Anvari MS; Khoob YT; Rabbani S; Sharifi F; Arzaghi SM; Fakhrzadeh H
    Daru; 2015 Jun; 23(1):32. PubMed ID: 26054525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of atherosclerotic plaque progression in the abdominal aorta of rabbits with 3T magnetic resonance imaging.
    Ma XH; Zhao L; Zhao QM; Feng TT; Shang JF; Zhang ZQ
    Chin Med J (Engl); 2012 Aug; 125(15):2714-8. PubMed ID: 22931980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
    Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Kihara T; Tanaka N; Nakaya K; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):222-8. PubMed ID: 19242355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate reduces tumor necrosis factor-alpha serum concentration and adipocyte secretion of hypercholesterolemic rabbits.
    Zhao SP; Wu J
    Clin Chim Acta; 2004 Sep; 347(1-2):145-50. PubMed ID: 15313152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging.
    Corti R; Fuster V; Fayad ZA; Worthley SG; Helft G; Chaplin WF; Muntwyler J; Viles-Gonzalez JF; Weinberger J; Smith DA; Mizsei G; Badimon JJ
    J Am Coll Cardiol; 2005 Jul; 46(1):106-12. PubMed ID: 15992643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
    Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
    Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E does not regress hypercholesterolemic atherosclerosis.
    Prasad K
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):231-41. PubMed ID: 19498106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.